Getting Rapid Diagnostic Test Data into the Appropriate Hands by Leveraging Pharmacy Staff and a Clinical Surveillance Platform: a Case Study from a US Community Hospital

Overview

Journal J Antimicrob Chemother

Publisher Oxford University Press

Specialty Infectious Diseases

Date 2024 Sep 19

PMID 39298364

Authors

Jeremy Frens

Tyler Baumeister

Emily Sinclair

Dustin Zeigler

John Hurst

Brandon Hill

Sonya McElmeel

Stephanie Le Page

Affiliations

Soon will be listed here.

Abstract

Objectives: To outline the procedural implementation and optimization of rapid diagnostic test (RDT) results for bloodstream infections (BSIs) and to evaluate the combination of RDTs with real-time antimicrobial stewardship team (AST) support plus clinical surveillance platform (CSP) software on time to appropriate therapy in BSIs at a single health system.

Methods: Blood culture reporting and communication were reported for four time periods: (i) a pre-BCID [BioFire® FilmArray® Blood Culture Identification (BCID) Panel] implementation period that consisted of literature review and blood culture notification procedure revision; (ii) a BCID implementation period that consisted of BCID implementation, real-time results notification via CSP, and creation of a treatment algorithm; (iii) a post-BCID implementation period; and (iv) a BCID2 implementation period. Time to appropriate therapy metrics was reported for the BCID2 time period.

Results: The mean time from BCID2 result to administration of effective antibiotics was 1.2 h (range 0-7.9 h) and time to optimal therapy was 7.6 h (range 0-113.8 h) during the BCID2 Panel implementation period. When comparing time to optimal antibiotic administration among patients growing ceftriaxone-resistant Enterobacterales, the BCID2 Panel group (mean 2.8 h) was significantly faster than the post-BCID Panel group (17.7 h; P = 0.0041).

Conclusions: Challenges exist in communicating results to the appropriate personnel on the healthcare team who have the knowledge to act on these data and prescribe targeted therapy against the pathogen(s) identified. In this report, we outline the procedures for telephonic communication and CSP support that were implemented at our health system to distribute RDT data to individuals capable of assessing results, enabling timely optimization of antimicrobial therapy.

References

Pollack L, Srinivasan A . Core elements of hospital antibiotic stewardship programs from the Centers for Disease Control and Prevention. Clin Infect Dis. 2014; 59 Suppl 3:S97-100. PMC: 6521960. DOI: 10.1093/cid/ciu542. View

Bai A, Showler A, Burry L, Steinberg M, Ricciuto D, Fernandes T . Impact of Infectious Disease Consultation on Quality of Care, Mortality, and Length of Stay in Staphylococcus aureus Bacteremia: Results From a Large Multicenter Cohort Study. Clin Infect Dis. 2015; 60(10):1451-61. DOI: 10.1093/cid/civ120. View

Wang F, Prier B, Bauer K, Mellett J . Pharmacist-driven initiative for management of bacteremia using a clinical decision support system. Am J Health Syst Pharm. 2018; 75(11 Supplement 2):S35-S41. DOI: 10.2146/ajhp170087. View

Kaye K, Pogue J . Infections Caused by Resistant Gram-Negative Bacteria: Epidemiology and Management. Pharmacotherapy. 2015; 35(10):949-62. DOI: 10.1002/phar.1636. View

Perez K, Olsen R, Musick W, Cernoch P, Davis J, Land G . Integrating rapid pathogen identification and antimicrobial stewardship significantly decreases hospital costs. Arch Pathol Lab Med. 2012; 137(9):1247-54. DOI: 10.5858/arpa.2012-0651-OA. View

Hossain B, Islam M, Rahman A, Marzan M, Rafiqullah I, Connor N . Understanding Bacterial Isolates in Blood Culture and Approaches Used to Define Bacteria as Contaminants: A Literature Review. Pediatr Infect Dis J. 2016; 35(5 Suppl 1):S45-51. DOI: 10.1097/INF.0000000000001106. View

Timbrook T, Morton J, McConeghy K, Caffrey A, Mylonakis E, LaPlante K . The Effect of Molecular Rapid Diagnostic Testing on Clinical Outcomes in Bloodstream Infections: A Systematic Review and Meta-analysis. Clin Infect Dis. 2016; 64(1):15-23. DOI: 10.1093/cid/ciw649. View

Kollef M . Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients. Clin Infect Dis. 2000; 31 Suppl 4:S131-8. DOI: 10.1086/314079. View

MacVane S, Nolte F . Benefits of Adding a Rapid PCR-Based Blood Culture Identification Panel to an Established Antimicrobial Stewardship Program. J Clin Microbiol. 2016; 54(10):2455-63. PMC: 5035429. DOI: 10.1128/JCM.00996-16. View

10.

Buehler S, Madison B, Snyder S, Derzon J, Cornish N, Saubolle M . Effectiveness of Practices To Increase Timeliness of Providing Targeted Therapy for Inpatients with Bloodstream Infections: a Laboratory Medicine Best Practices Systematic Review and Meta-analysis. Clin Microbiol Rev. 2015; 29(1):59-103. PMC: 4771213. DOI: 10.1128/CMR.00053-14. View

11.

Cosgrove S . The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs. Clin Infect Dis. 2005; 42 Suppl 2:S82-9. DOI: 10.1086/499406. View

12.

Barlam T, Cosgrove S, Abbo L, MacDougall C, Schuetz A, Septimus E . Implementing an Antibiotic Stewardship Program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clin Infect Dis. 2016; 62(10):e51-77. PMC: 5006285. DOI: 10.1093/cid/ciw118. View

13.

Hanon F, Monnet D, Sorensen T, Molbak K, Pedersen G, Schonheyder H . Survival of patients with bacteraemia in relation to initial empirical antimicrobial treatment. Scand J Infect Dis. 2002; 34(7):520-8. DOI: 10.1080/00365540110080827. View

14.

. ASHP statement on the pharmacist's role in antimicrobial stewardship and infection prevention and control. Am J Health Syst Pharm. 2010; 67(7):575-7. DOI: 10.2146/sp100001. View

15.

Murphy S, Xu J, Kochanek K, Curtin S, Arias E . Deaths: Final Data for 2015. Natl Vital Stat Rep. 2017; 66(6):1-75. View

16.

Forrest G, Van Schooneveld T, Kullar R, Schulz L, Duong P, Postelnick M . Use of electronic health records and clinical decision support systems for antimicrobial stewardship. Clin Infect Dis. 2014; 59 Suppl 3:S122-33. DOI: 10.1093/cid/ciu565. View

17.

Walsh T, Bremmer D, Moffa M, Trienski T, Buchanan C, Stefano K . Impact of an Antimicrobial Stewardship Program-bundled initiative utilizing Accelerate Pheno™ system in the management of patients with aerobic Gram-negative bacilli bacteremia. Infection. 2021; 49(3):511-519. PMC: 8159835. DOI: 10.1007/s15010-021-01581-1. View

18.

Wenzler E, Wang F, Goff D, Prier B, Mellett J, Mangino J . An Automated, Pharmacist-Driven Initiative Improves Quality of Care for Staphylococcus aureus Bacteremia. Clin Infect Dis. 2017; 65(2):194-200. DOI: 10.1093/cid/cix315. View

19.

Kang C, Kim S, Beom Park W, Lee K, Kim H, Kim E . Bloodstream infections caused by antibiotic-resistant gram-negative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome. Antimicrob Agents Chemother. 2005; 49(2):760-6. PMC: 547233. DOI: 10.1128/AAC.49.2.760-766.2005. View

20.

Dargere S, Cormier H, Verdon R . Contaminants in blood cultures: importance, implications, interpretation and prevention. Clin Microbiol Infect. 2018; 24(9):964-969. DOI: 10.1016/j.cmi.2018.03.030. View